- This study assessed neonatal stroke incidence, presentation, management, and short-term outcomes in the UK and Ireland.
- Researchers conducted an active surveillance study and meta-analysis, identifying 68 neonatal stroke cases.
- The UK incidence was 9.0 per 100,000 live births (95% CI 6.9 to 11.6), with three-quarters being arterial ischaemic.
- The authors concluded neonatal stroke is rare, with distinct subtypes requiring varied management strategies.
- These findings highlight the need for improved understanding and standardized guidelines for neonatal stroke care.
Understanding Neonatal Stroke: Epidemiology and Early Clinical Patterns
Neonatal seizures are a common and concerning neurological event, often signaling underlying brain injury from causes such as hypoxic-ischemic encephalopathy or stroke [1, 2, 3]. These events carry a significant risk for adverse long-term outcomes, including post-neonatal epilepsy, cerebral palsy, and developmental delay [4, 5, 3]. While advances in neuroimaging and electroencephalography (EEG) have improved diagnosis, management strategies can vary, highlighting a need for clearer, evidence-based guidance [2, 6]. A recent surveillance study from the UK and Ireland now provides precise data on the epidemiology and clinical characteristics of neonatal stroke, a critical contributor to neurological morbidity in newborns.
Current Incidence and Subtype Characteristics
A new study provides a detailed epidemiological snapshot of neonatal stroke across the UK and Ireland. Using an active surveillance model, where clinicians proactively report cases through the British Paediatric Surveillance Unit, the researchers gathered comprehensive data on infants presenting with stroke at less than 90 days of age. The investigation, which ran from March 2022 to April 2023, included both term and preterm infants, with clinicians submitting questionnaires and de-identified neuroimages via a dedicated platform. This methodology ensured a robust and standardized dataset for analysis. Over the study period, 68 cases of neonatal stroke were identified, establishing a UK incidence of 9.0 per 100,000 live births (95% CI 6.9 to 11.6). This figure offers a contemporary benchmark for clinicians. Further analysis of the stroke characteristics revealed that three-quarters of cases were arterial ischaemic and unilateral. This predominance of a specific stroke subtype helps inform diagnostic expectations and resource planning in neonatal intensive care settings.
Distinct Presentations and Associated Perinatal Factors
The investigation revealed clinically significant differences in presentation based on stroke subtype, which can aid in differential diagnosis. Neonates with arterial ischaemic stroke and cerebral venous sinus thrombosis (CVST) most commonly presented with seizures, typically at 2–3 days of age. In contrast, those with haemorrhagic stroke were more likely to present with encephalopathy, usually within the first ten days of life. These distinct temporal and symptomatic patterns can help clinicians prioritize diagnostic pathways when evaluating a neonate with acute neurological signs. The study also identified a strong link between neonatal stroke and in utero fetal distress. This association was supported by objective perinatal data: 61% of the affected infants had an umbilical cord pH below 7.25, and 28% required significant resuscitation at birth. These findings suggest that a history of perinatal compromise should increase the index of suspicion for stroke, potentially prompting earlier neuroimaging and intervention.
Initial Management and Short-Term Outcomes
The study's findings on management reflect the acute clinical challenges posed by neonatal stroke. Seizure control was a clear priority, as 87% of infants with arterial ischaemic stroke and CVST received antiseizure medications. This high rate of intervention aligns with the frequent presentation of seizures in these subtypes and underscores the focus on stabilizing the infant's neurological status. Regarding short-term outcomes, the data show that most infants were stabilized relatively quickly, with 82% discharged home after a median hospital stay of 12 days. However, the need for continued management was evident, as 42% of these infants were discharged on antiseizure medications, indicating a persistent risk that requires careful outpatient monitoring. Post-discharge care was notably multidisciplinary, with follow-up involving paediatric or neonatal services for 91% of infants, physiotherapy for 77%, and paediatric neurology for 63%. This comprehensive approach highlights the recognized need for long-term, coordinated care to address the potential motor, developmental, and neurological sequelae of neonatal stroke.
Contextualizing Findings and Future Directions
To validate their findings, the researchers conducted a meta-analysis of national surveillance studies that included a total of 3,607,864 infants. This broader analysis confirmed that the incidence and associated risk factors for neonatal stroke in the UK and Ireland are consistent with data from Germany and Australia, reinforcing the generalizability of the results. Despite this epidemiological consistency, the study uncovered a significant gap in clinical practice: formal guidelines for managing neonatal stroke were available in only a quarter of the reporting hospitals. This lack of standardized protocols may contribute to variability in care and outcomes, representing a clear opportunity for quality improvement. The study concludes that neonatal stroke is a rare but complex condition with distinct subtypes that demand different clinical approaches. This heterogeneity underscores the need for further research to refine diagnostic criteria, establish evidence-based management guidelines, and ultimately improve long-term neurological outcomes for this vulnerable population.
References
1. Westergren H, Finder M, Marell-Hesla H, Wickström R. Neurological outcomes and mortality after neonatal seizures with electroencephalographical verification. A systematic review. European Journal of Paediatric Neurology. 2024. doi:10.1016/j.ejpn.2024.02.005
2. Pressler R, Abend NS, Auvin S, et al. Treatment of seizures in the neonate: Guidelines and consensus‐based recommendations—Special report from the ILAE Task Force on Neonatal Seizures. Epilepsia. 2023. doi:10.1111/epi.17745
3. Trowbridge S, Condie LO, Landers JR, et al. Effect of neonatal seizure burden and etiology on the long‐term outcome: data from a randomized, controlled trial. Annals of the Child Neurology Society. 2023. doi:10.1002/cns3.8
4. Mastrangelo M, Gasparri V, Bernardi K, Foglietta S, Ramantani G, Pisani F. Epilepsy Phenotypes of Vitamin B6-Dependent Diseases: An Updated Systematic Review. Children. 2023. doi:10.3390/children10030553
5. Falsaperla R, Scalia B, Giugno A, et al. Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature. The Italian Journal of Pediatrics/Italian journal of pediatrics. 2021. doi:10.1186/s13052-021-01027-2
6. McKee JL, Kaufman MC, Gonzalez AK, et al. Leveraging electronic medical record-embedded standardised electroencephalogram reporting to develop neonatal seizure prediction models: a retrospective cohort study. The Lancet Digital Health. 2023. doi:10.1016/s2589-7500(23)00004-3